Clinical Trials

Find trials by condition, location & phase

Drug Monographs

Browse drug monographs and information

Explore organizations and their profiles

Latest updates on trials and healthcare

Approved products by global authorities

AI-Powered Research

Discover powerful insights with advanced AI analysis tools for clinical trials.

Premium Access

Get unlimited access to our comprehensive pharmaceutical database and analytics.

MASSACHUSETTS GENERAL HOSPITAL

🇺🇸United States

Country: 🇺🇸United States

Ownership: -

Established: 1811-01-01

Employees: -

Market Cap: -

Website: http://www.massgeneral.org/international

Clinical Trials

Validation of Thermal Imaging to Detect Pneumonia

Terminated

Conditions: Pneumonia

Interventions: Diagnostic Test: Thermal image

First Posted Date: 2017-08-25

Last Posted Date: 2020-11-13

Lead Sponsor: Massachusetts General Hospital

Target Recruit Count: 22

Registration Number: NCT03261479

Locations: 🇺🇸
Ryan MD Carroll, Boston, Massachusetts, United States

Individualizing Automated Closed Loop Glucose Control Through Pharmacokinetic Profiling in an Insulin-Only Bionic Pancreas

Phase 2

Terminated

Conditions: Type 1 Diabetes Mellitus

Interventions: Drug: Humalog
Drug: BC222 insulin lispro
Drug: Novolog
Device: Bionic Pancreas

First Posted Date: 2017-08-25

Last Posted Date: 2022-12-09

Lead Sponsor: Massachusetts General Hospital

Target Recruit Count: 20

Registration Number: NCT03262116

Locations: 🇺🇸
Massachusetts General Hospital, Boston, Massachusetts, United States

Mechanistic Studies on Video-guided Acupuncture Imagery Treatment of Knee Pain

Not Applicable

Completed

Conditions: Osteoarthritis, Knee

Interventions: Device: Acupuncture

First Posted Date: 2017-08-25

Last Posted Date: 2023-12-01

Lead Sponsor: Massachusetts General Hospital

Target Recruit Count: 125

Registration Number: NCT03261505

Locations: 🇺🇸
Athinoula A. Martinos Center for Biomedical Imaging, Charlestown, Massachusetts, United States

Esophageal Deviation in Atrial Fibrillation Ablation

Not Applicable

Completed

Conditions: Atrial Fibrillation

Interventions: Device: DV8

First Posted Date: 2017-08-25

Last Posted Date: 2021-06-30

Lead Sponsor: Massachusetts General Hospital

Target Recruit Count: 47

Registration Number: NCT03261973

Locations: 🇺🇸
Massachusetts General Hospital, Boston, Massachusetts, United States

Feasibility of Outpatient Closed Loop Control With the iLet Bionic Pancreas in Cystic Fibrosis Related Diabetes

Not Applicable

Completed

Conditions: Cystic Fibrosis-related Diabetes

Interventions: Device: Bionic Pancreas
Other: Usual Care

First Posted Date: 2017-08-23

Last Posted Date: 2023-07-20

Lead Sponsor: Massachusetts General Hospital

Target Recruit Count: 22

Registration Number: NCT03258853

Locations: 🇺🇸
Massachusetts General Hospital, Boston, Massachusetts, United States

Nivolumab in Combination With Chemotherapy, or Nivolumab in Combination With Ipilimumab, in Advanced EGFR-Mutant or ALK-Rearranged NSCLC

Phase 2

Completed

Conditions: Lung Cancer

Interventions: Drug: Nivolumab
Drug: Carboplatin
Drug: Ipilimumab
Drug: pemetrexed

First Posted Date: 2017-08-21

Last Posted Date: 2020-11-04

Lead Sponsor: Massachusetts General Hospital

Target Recruit Count: 9

Registration Number: NCT03256136

Locations: 🇺🇸
Beth Israel Deaconess Medical Center, Boston, Massachusetts, United States
🇺🇸
Dana Farber Cancer Institute, Boston, Massachusetts, United States
🇺🇸
Massachusetts general Hospital, Boston, Massachusetts, United States

Effect of Combined Morphine and Duloxetine on Chronic Pain

Phase 4

Completed

Conditions: Chronic Low Back Pain
Chronic Neck Pain

Interventions: Drug: Morphine
Drug: Placebo
Drug: Duloxetine

First Posted Date: 2017-08-15

Last Posted Date: 2024-11-14

Lead Sponsor: Massachusetts General Hospital

Target Recruit Count: 81

Registration Number: NCT03249558

Locations: 🇺🇸
Karina de Sousa, Boston, Massachusetts, United States

Patient Navigation for Colorectal Cancer Screening for Patients With Mental Illness and/or Substance Use Disorder

Not Applicable

Completed

Conditions: ColoRectal Cancer Screening

Interventions: Behavioral: patient navigation

First Posted Date: 2017-08-10

Last Posted Date: 2018-03-22

Lead Sponsor: Massachusetts General Hospital

Target Recruit Count: 380

Registration Number: NCT03244787

Patient-specific, Effective, and Rational Functional Connectivity Targeting for DBS in OCD

Withdrawn

Conditions: Obsessive-Compulsive Disorder

First Posted Date: 2017-08-10

Last Posted Date: 2022-05-17

Lead Sponsor: Massachusetts General Hospital

Registration Number: NCT03244852

Locations: 🇺🇸
Massachusetts General Hospital, Charlestown, Massachusetts, United States

LMWH Vs Aspirin for VTE Prophylaxis in Orthopaedic Oncology

Phase 4

Conditions: Bone Metastases
Soft Tissue Sarcoma
Bone Sarcoma
Hematoma
Anticoagulant-induced Bleeding
Sarcoma
Venous Thromboembolism

Interventions: Drug: Enoxaparin 40Mg/0.4mL Prefilled Syringe
Drug: Aspirin 325mg

First Posted Date: 2017-08-09

Last Posted Date: 2024-12-31

Lead Sponsor: Massachusetts General Hospital

Target Recruit Count: 2868

Registration Number: NCT03244020

Locations: 🇺🇸
University of California Los Angeles Health, Los Angeles, California, United States
🇺🇸
Moffitt Cancer Center, Tampa, Florida, United States
🇺🇸
Louisiana State University Health, New Orleans, Louisiana, United States

and more 7 locations

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy